Lipid‑based drug delivery systems—particularly liposomes—continue to reshape how researchers approach diseases that have long resisted conventional therapies. Their modularity, biocompatibility, and ability to encapsulate diverse therapeutic payloads make them especially valuable in areas such as neurodegeneration and endocrine dysregulation, where targeted, sustained, or...